A Phase IIB Randomized, Placebo-Controlled Trial of Piog

Project: Research project

Project Details

Description

A Phase IIB Randomized, Placebo-Controlled Trial of Pioglitazone for Oral Pre-Malignant Lesions: An Inter- Consortium Collaborative Study
StatusFinished
Effective start/end date9/1/109/15/14

Funding

  • UNIVERSITY OF WISCONSIN-MADISON
  • NIH NATIONAL CANCER INSTITUTE (NCI)